CH628639A5 - Process for the preparation of furanose derivatives - Google Patents
Process for the preparation of furanose derivatives Download PDFInfo
- Publication number
- CH628639A5 CH628639A5 CH53176A CH53176A CH628639A5 CH 628639 A5 CH628639 A5 CH 628639A5 CH 53176 A CH53176 A CH 53176A CH 53176 A CH53176 A CH 53176A CH 628639 A5 CH628639 A5 CH 628639A5
- Authority
- CH
- Switzerland
- Prior art keywords
- deoxy
- lactone
- carboxymethyl
- compounds
- formula
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/32—Oxygen atoms
- C07D307/33—Oxygen atoms in position 2, the oxygen atom being in its keto or unsubstituted enol form
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/32—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/01—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing oxygen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H9/00—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical
- C07H9/02—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical the hetero ring containing only oxygen as ring hetero atoms
- C07H9/04—Cyclic acetals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ZA00750317A ZA75317B (en) | 1975-01-16 | 1975-01-16 | Novel chemical compounds and their use as intermediates |
ZA751985 | 1975-04-01 |
Publications (1)
Publication Number | Publication Date |
---|---|
CH628639A5 true CH628639A5 (en) | 1982-03-15 |
Family
ID=27131118
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CH53176A CH628639A5 (en) | 1975-01-16 | 1976-01-16 | Process for the preparation of furanose derivatives |
Country Status (9)
Country | Link |
---|---|
JP (1) | JPS5195060A (xx) |
CH (1) | CH628639A5 (xx) |
DE (1) | DE2601333A1 (xx) |
DK (1) | DK17876A (xx) |
FR (2) | FR2318172A1 (xx) |
GB (1) | GB1532551A (xx) |
IE (1) | IE42941B1 (xx) |
LU (1) | LU74144A1 (xx) |
NL (1) | NL7600367A (xx) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4048194A (en) * | 1976-04-14 | 1977-09-13 | The Upjohn Company | 6α-Methoxy-4α-hydroxy-2β-hydroxymethyl-3.alpha.-tetrahydropyranacetic acid 4α γ-lactone ethers and acylates |
US4549030A (en) * | 1982-12-13 | 1985-10-22 | The Upjohn Company | Organic compounds and process |
US5866602A (en) * | 1995-12-22 | 1999-02-02 | Alcon Laboratories, Inc. | Keto-substituted tetrahydrofuran analogs of prostaglandins as ocular hypotensives |
US5814660A (en) * | 1995-12-22 | 1998-09-29 | Alcon Laboratories, Inc. | 9-oxa prostaglandin analogs as ocular hypotensives |
EP0869794B1 (en) * | 1995-12-22 | 2004-08-11 | Alcon Laboratories, Inc. | Substituted tetrahydrofuran analogs of prostaglandins as ocular hypotensives |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2436332A1 (de) * | 1974-07-27 | 1976-02-12 | Knoll Ag | Substituierte tetrahydrofurane und verfahren zu deren herstellung |
-
1976
- 1976-01-07 GB GB553/76A patent/GB1532551A/en not_active Expired
- 1976-01-08 LU LU74144A patent/LU74144A1/xx unknown
- 1976-01-14 JP JP51003766A patent/JPS5195060A/ja active Pending
- 1976-01-15 DE DE19762601333 patent/DE2601333A1/de not_active Ceased
- 1976-01-15 IE IE74/76A patent/IE42941B1/en unknown
- 1976-01-15 FR FR7600953A patent/FR2318172A1/fr active Granted
- 1976-01-15 NL NL7600367A patent/NL7600367A/xx not_active Application Discontinuation
- 1976-01-16 CH CH53176A patent/CH628639A5/de not_active IP Right Cessation
- 1976-01-16 DK DK17876*#A patent/DK17876A/da not_active Application Discontinuation
- 1976-10-13 FR FR7630719A patent/FR2318164A1/fr active Granted
Also Published As
Publication number | Publication date |
---|---|
IE42941L (en) | 1976-07-16 |
IE42941B1 (en) | 1980-11-19 |
JPS5195060A (xx) | 1976-08-20 |
NL7600367A (nl) | 1976-07-20 |
DE2601333A1 (de) | 1976-07-22 |
GB1532551A (en) | 1978-11-15 |
FR2318172B1 (xx) | 1979-03-23 |
DK17876A (da) | 1976-07-17 |
FR2318164A1 (fr) | 1977-02-11 |
LU74144A1 (xx) | 1977-07-22 |
FR2318164B1 (xx) | 1979-02-16 |
FR2318172A1 (fr) | 1977-02-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CH632481A5 (de) | Verfahren zur herstellung eines optisch aktiven norpinens. | |
DE69909455T2 (de) | Polyethoxylierte ascorbinsäurederivate als neue antioxidantien und verfahren zu ihrer herstellung | |
DE69215070T2 (de) | Verfahren zur herstellung von 3-dpa-lacton | |
DE2416193C2 (de) | Prostaglandin-Analoge, Verfahren zu ihrer Herstellung sowie ihre Verwendung als cytoprotektives Mittel | |
DE2858694C2 (xx) | ||
CH628639A5 (en) | Process for the preparation of furanose derivatives | |
CH509297A (de) | Verfahren zur Herstellung von in 17-Stellung durch ungesättigte Kohlenwasserstoffreste substituierten 11,13B-Dialkylgon-4-en-3,17B-diolen | |
EP0043967B1 (de) | 2,9-Dioxatricyclo(4,3,1,0(3,7))decane | |
DE2463208C2 (de) | Verfahren zur Herstellung von optisch aktiven bicyclischen Lactondiolen und deren racemischen Gemischen | |
DE2611788C2 (de) | Fluorprostaglandine, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Mittel | |
CH617186A5 (xx) | ||
EP0000207A1 (de) | Neue Prostaglandinderivate, deren Herstellung und pharmazeutische Präparate und Zwischenprodukte | |
EP0162235B1 (de) | Enantiomerenreine acetalisch mono-geschützte Diole, deren Herstellung und Verwendung | |
CH628634A5 (de) | Verfahren zur herstellung von 2,2'-bis(3,4-epoxy-5-oxotetrahydropyran)aether und produkt. | |
AT239454B (de) | Verfahren zur Herstellung von 20-Cycloketalderivaten des 3β,5,17α-Trihydroxy-6β-methyl-16-methylen-5α-pregnan-20-ons | |
DE3536956A1 (de) | Pyranderivate und ein verfahren zu ihrer herstellung | |
AT372080B (de) | Verfahren zum herstellen von neuen optisch aktiven prost-5-en-13-in-carbonsaeurederivaten | |
DE69108587T2 (de) | Verfahren und Zwischenprodukte zur Herstellung von optisch aktiven Chromanderivaten. | |
CH617424A5 (xx) | ||
AT368524B (de) | Verfahren zur herstellung von neuen in 16-stellung disubstituierten 3-ketosteroiden | |
AT238888B (de) | Verfahren zur Herstellung von neuen, in 16-Stellung durch eine Methylgruppe substituierten 3α-Hydroxy-11,20-dioxo-21-pregnanglyoxylsäuren | |
DE2460977A1 (de) | Sterisch einheitliche 11-oxaprostaglandine und verfahren zu deren herstellung | |
AT338755B (de) | Verfahren zur herstellung von optisch aktiven cis-2-(2-hydroxyathyl)-3-cyclopenten-1-ol | |
AT361642B (de) | Verfahren zur herstellung von neuen cholesterinderivaten | |
DE2560493C2 (de) | 2,9-Dioxatricyclo[4,3,1,0↑3↑↑,↑↑7↑]decane |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PL | Patent ceased |